#elililly — Public Fediverse posts

https://www.europesays.com/ch/64872/ Roche Receives CE Mark for Alzheimer’s Disease Blood Test #Alzheimeru2019sDisease #BloodTest #CEMark #ClinicalDiagnostics #CognitiveDecline #dementia #DiagnosticAssay #EarlyDiagnosis #EliLilly #HealthcareInnovation #MinimallyInvasiveTesting #neurology #PrimaryCare #Roche #SecondaryCare

https://www.europesays.com/ch/63967/ Roche cleared to launch early Alzheimer’s test in EU: company #Alzheimer’s #Alzheimer'sDisease #alzheimersdisease #BloodTest #CEMarking #DementiaDiagnosis #DiagnosticTesting #EarlyDetection #ElecsysPTau217 #EliLilly #EUApproval #HealthcareInnovation #NeurodegenerativeDisease #PharmaceuticalCompany #Pharmaceuticals #ProteinIrregularities #Roche #RocheDiagnostics #TimelyIntervention

https://www.europesays.com/dk/77475/ These 2 Stocks Have More Upside #EliLilly #NovoNordisk #NYSE #Pfizer

https://www.europesays.com/dk/75598/ Novo Nordisk Share Price: Obesity Pill Ka Craze Hai, Par Profitability Ki Testing Shuru! #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket

https://www.europesays.com/dk/75448/ Novo Nordisk’s Obesity Pill Demand Soars, Profitability Faces Tough Test #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket

Wall Street Journal: The quest to use AI to help find new drugs. “Lilly first announced a partnership with chip-maker Nvidia in October to build what it called the industry’s most powerful supercomputer, and expanded that in January with a $1 billion, five-year collaboration mixing their scientists and engineers in a new Bay Area lab aimed at discovering new medicines with AI tools. They […]

https://www.europesays.com/dk/?p=74979 Novo Nordisk’s Weight-Loss Pill Fuels Fierce Rivalry with Eli Lilly #EliLilly #MarketShare #NovoNordisk #ObesityDrugs #ObesityTreatment #PharmaceuticalCompetition #PrescriptionGrowth #PricePressures #Wegovy #WeightLossPill

https://www.europesays.com/dk/73952/ Is Novo Nordisk A/S (NVO) A Good Stock To Buy Now? #EliLilly #MarketShare #NovoNordisk #PharmaceuticalProducts #UnfairAdvantage

https://www.europesays.com/dk/65079/ Why Eli Lilly Is Leaving Novo Nordisk in the Dust #EliLilly #HealthcareStocks #MarketValue #NovoNordisk #WeightLoss #WeightManagement

Global drug makers face pricing pressure as China targets affordable healthcare

Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
https://www.newsbeep.com/us/571163/

Global drug makers face pricing pressure as China targets affordable healthcare

Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #astrazeneca #Beijing #China #donaldtrump #EliLilly #Gardasil #Health #keytruda #Merck #Mounjaro #Roche #Sanofi #Washington
https://www.newsbeep.com/us/571163/

Global drug makers face pricing pressure as China targets affordable healthcare

Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
#NewsBeep #News #Healthcare #AstraZeneca #Beijing #China #DonaldTrump #EliLilly #Gardasil #Health #healthcare #Keytruda #merck #Mounjaro #Roche #SANOFI #UK #UnitedKingdom #UnitedStates #Washington
https://www.newsbeep.com/uk/518906/

https://www.europesays.com/uk/879345/ Global drug makers face pricing pressure as China targets affordable healthcare #AstraZeneca #Beijing #China #DonaldTrump #EliLilly #Gardasil #Health #Healthcare #Keytruda #Merck #Mounjaro #Roche #Sanofi #UK #UnitedKingdom #UnitedStates #Washington

https://www.europesays.com/ie/418523/ No ‘immediate cliff edge’ for Ireland as Trump announces 100% tariff on pharma imports – The Irish Times #amgen #astrazeneca #bdo #BreakingNews #BreakingNews #ChambersIreland #Éire #EliLilly #EY #FeaturedNews #FeaturedNews #Headlines #IE #Ireland #LatestNews #LatestNews #MainNews #MainNews #News #NovoNordisk #pfizer #TopStories #TopStories #UsTariffs

https://www.europesays.com/ch/42689/ Wafaa Mamilli To Join Roche As Chief Digital Technology Officer #CDO #cio #CTO #EliLilly #Roche #WafaaMamilli #Zoetis

https://www.europesays.com/dk/35540/ Novo Nordisk’s ‘Semaglutide’ gains weight against Eli Lilly in battle for market share #AntiObesityDrugs #cipla #DiabetesMedication #EliLilly #GLP1Market #MarketShare #NovoNordisk #ozempic #semaglutide #Tirzepatide #Wegovy

#ARAI Testing #NewSUV in #Pune Chery Jaecoo
https://kensbookinfo.blogspot.com/p/business.html#5

#AI Agents Love to Hold #Bitcoin and Spend Stablecoins,
https://kensbookinfo.blogspot.com/p/etc-varied.html#6

#EliLilly launches program to help boost employer coverage
https://kensbookinfo.blogspot.com/p/business.html#40

In defense of student walkout protests against #ICE
https://kensbookinfo.blogspot.com/p/politics.html#14

#Vermonters face federal clean water changes
https://kensbookinfo.blogspot.com/p/us-capitals.html#Montpelier

#Iranian artists react to current events
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris

#US Deputy Secy Landau
https://kensbookinfo.blogspot.com/p/cities.html#41a

#ARAI Testing #NewSUV in #Pune Chery Jaecoo
https://kensbookinfo.blogspot.com/p/business.html#5

#AI Agents Love to Hold #Bitcoin and Spend Stablecoins,
https://kensbookinfo.blogspot.com/p/etc-varied.html#6

#EliLilly launches program to help boost employer coverage
https://kensbookinfo.blogspot.com/p/business.html#40

In defense of student walkout protests against #ICE
https://kensbookinfo.blogspot.com/p/politics.html#14

#Vermonters face federal clean water changes
https://kensbookinfo.blogspot.com/p/us-capitals.html#Montpelier

#Iranian artists react to current events
https://kensbookinfo.blogspot.com/p/world-capitals.html#Paris

#US Deputy Secy Landau
https://kensbookinfo.blogspot.com/p/cities.html#41a

https://www.europesays.com/ie/347518/ Why haven’t Trump’s tariffs caused a downturn in the US? – The Irish Times #Amazon #Business #Canada #CostOfLiving #DonaldTrump #Éire #EliLilly #IE #Ireland #Mexico #Mounjaro #TrumpPresidency #ups #UsTariffs #Zepbound

Three multinationals pay 46% of Ireland’s Corporation Tax.

Ireland’s fiscal watchdog has estimated that almost half of the Corporation Tax collected by the State is paid by three multinational companies.

The three multinationals are not named but they are understood to be Apple, Microsoft and pharmaceutical group Eli Lilly.

https://mediafaro.org/article/20260219-three-multinationals-pay-46-of-irelands-corporation-tax?mf_channel=mastodon&action=forward

#Ireland #CorporationTax #Business #Tax #IFA #Apple #Microsoft #EliLilly #Tech #Pharma #Pharmaceutical

Could gene editing offer the one-time fix for artery-clogging cholesterol?

WASHINGTON (AP) — Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment tha…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Health #AmericanHeartAssociation #APTopNews #BeWell #BeWell-Health #Business #Cholesterol #Cleveland #CRISPRTherapeuticsAG #EliLilly #KiranMusunuru #Lifestyle #Medication #Science #SendtoAppleNews #StevenNissen
https://www.newsbeep.com/us/463855/

CAR-T works. But it’s bespoke: collect cells, engineer, ship back — often 3–6 weeks. Lilly’s up-to-$2.4bn Orna deal bets on in-vivo CAR-T (circular RNA + LNPs) to make an autoimmune “immune reset” scalable. https://biotech.industryexaminer.com/lilly-orna-in-vivo-car-t-circular-rna-autoimmune/
#Biotech #CART #EliLilly #TechNews #BiotechNews

Mark Cuban Praises TrumpRx Deal With Eli Lilly, Novo Nordisk

When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #bigglp-1drug #businessinsider #clearpricetag #Cost #deal #EliLilly #Health #MarkCuban #Medicare #NovoNordisk #ozempiccost #PBM #pharmacycost #PresidentTrump #price #rightthursday
https://www.newsbeep.com/us/277423/

Pharmaceutical corporation Eli Lilly and Company plans to build a $6.5 billion manufacturing hub near Lake Houston, the company announced Tuesday. 

https://www.houstonpublicmedia.org/articles/news/business/2025/09/23/531691/eli-lilly-announces-weight-loss-drug-to-be-manufactured-at-6-5-billion-site-in-houston/

#Business #HealthScience #Houston #Local #MedicineWellness #News #EliLilly #GovGregAbbott #LakeHouston #PharmaceuticalCompanies #WeightLoss #WeightLossDrugs

Startup spun out from a Nobel Laureate’s lab partners with Eli Lilly to fight cancer with AI - Lila Biologics co-founders CEO Jake Kraft, left, and Chief Scientist Anindya Roy.... - https://www.geekwire.com/2025/seattle-biotech-startup-collaborates-with-eli-lilly-in-pursuit-of-therapy-for-solid-tumors/ #health/lifesciences #lilabiologics #proteindesign #davidbaker #bakerlab #elililly #cancer #tumors

Ozempic, other weight-loss drug makers face lawsuits. Here’s what we know

Claim: Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #diabetesmedication #diabetesmedications #EasternDistrict #EliLilly #Health #JudgeKarenSpencerMarston #multidistrictlitigation #NovoNordisk #Ozempic #pharmaceuticalcompanies #Type2Diabetes #VisionLoss #weightloss
https://www.newsbeep.com/us/111709/

Ozempic, other weight-loss drug makers face lawsuits. Here’s what we know

Claim: Pharmaceutical companies behind weight loss and diabetes medication such as Ozempic are facing…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #diabetesmedication #diabetesmedications #EasternDistrict #EliLilly #Health #JudgeKarenSpencerMarston #multidistrictlitigation #NovoNordisk #Ozempic #pharmaceuticalcompanies #Type2Diabetes #VisionLoss #weightloss
https://www.newsbeep.com/us/111709/

Trump: the gift that keeps on giving!

"The price of the weight loss jab Mounjaro will rise by up to 170% in the UK, its US manufacturer has said, as Donald Trump ramps up pressure on drugmakers to increase their prices for Europeans so that they can make them more affordable for Americans.

Eli Lilly has said it will increase the price of the drug from September, with a month’s supply of the highest dose rising from £122 to £303.

https://www.theguardian.com/business/2025/aug/14/eli-lilly-uk-price-weight-loss-jab-mounjaro-trump?CMP=share_btn_url

#EliLilly #Trump #PriceGouging

#EliLilly’s #Obesity #Pill Appears to Work as Well as Injected #GLP1s

https://www.wired.com/story/lilly-obesity-pill-effective-orforglipron-injected-glp-1-ozempic/

Novo Nordisk CEO resigns amid fierce competition in obesity drug market, with stock price falling to one-third of its peak as Eli Lilly's Zepbound gains market share.
#YonhapInfomax #NovoNordisk #CEOResignation #ObesityDrugMarket #StockPrice #EliLilly #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=63634

Wow, nothing like an "Access Denied" page to keep us on the edge of our seats! 😴 Apparently, Eli Lilly's weight loss #pill is so groundbreaking that even the internet doesn't have permission to know about it. 🚫🔍 #SecretiveScience
https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html #AccessDenied #EliLilly #WeightLoss #SecretiveScience #GroundbreakingInnovation #HackerNews #ngated

Eli Lilly will soon release key data on its weight loss pill orforglipron

https://www.cnbc.com/2025/03/24/eli-lilly-to-release-weight-loss-pill-orforglipron-trial-data-.html

#HackerNews #EliLilly #Orforglipron #WeightLoss #Pill #HealthInnovation #ClinicalTrials

Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled in one of the biggest medical controversies in recent years. https://www.japantimes.co.jp/news/2024/09/21/world/science-health/alzheimers-drugs-controversy/ #worldnews #sciencehealth #dementia #aging #alzheimer039s #eisai #biogen #elililly #drugs #medicine #brain

Abbott plans marketing push for glucose monitors beyond diabetes  — Morphic kept it simple in M&A maneuvers, staying focused on Lilly to reel in $3.2B buyout— FDA launches innovation hub to spur rare disease R&D —http://bit.ly/w28kSd #cgms #glucosemonitoring #abbottlabs #elililly #innovation #fda #rarediseases #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

US government appeals Gilead's trial win in Truvada, Descovy patent fight—Lilly’s Mounjaro helps patients lose more weight than Novo’s Ozempic — FTC report finds PBM power has “dire consequences” —http://bit.ly/w28kSd #gileadsciences #patents #elililly #mounjaro #ozempic #novonordisk #ftc #pbms #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster—GLP-1s may cut risk of 10 obesity-related cancers in diabetics —Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births —http://bit.ly/w28kSd #mergersandacquistions #elililly #ibd #takeda #glp1 #novonordisk #diabetes #cancer #pfizer #rsv #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

5 FDA decisions to watch in the second half of 2024—Lilly sees path for Zepbound’s label expansion with phase III sleep apnea win —BMS gets FDA approval for Krazati in colorectal cancer—http://bit.ly/w28kSd #fda #elililly #sleepapnea #bristolmyerssquibb #colorectalcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Biopharma dealmaking continues to rise, but M&A values hold steady—Vanda rejects buyout offers, pans 'opportunistic attempts' at securing its shares at a discount —Lilly files more lawsuits to curb sales of counterfeit Mounjaro—http://bit.ly/w28kSd #mergersandacquisitions #vandapharma #elililly #counterfeitdrugs #mounjaro #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—http://bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

After M&A stretch, Pfizer CEO says company needs 'breathing period' from large deals—Behind Big Pharma’s layoffs — is there an end in sight? — Lilly Alzheimer’s drug gets unanimous backing of FDA panel—http://bit.ly/w28kSd #pfizer #bigpharma #layoffs #alzheimers #elililly #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Moderna’s COVID-Flu combo shot beats separate vaccines in phase III study—FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date — Boehringer, Lilly face off in MASH at EASL—http://bit.ly/w28kSd #moderna #vaccines #flu #covid19 #alzheimers #fda #eisai #biogen #elililly #mash #easl #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

GSK, after 11-month romance, buys oligonucleotide partner Elsie for up to $50M—FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety — FDA panel recommends new COVID vaccines for JN.1 lineage by fall—http://bit.ly/w28kSd #gsk #oligonucleotides #fda #elililly #alzheimers #covid19 #vaccines #mergersandacquisitions #radiopharmaceuticals #ipos #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

ASCO: AstraZeneca's Tagrisso, Imfinzi break new ground in lung cancer—with one standing ovation—Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up — Eli Lilly adds ALS drug prospect with QurAlis deal--http://bit.ly/w28kSd #asco2024 #oncology #cancer #astrazeneca #moderna #elililly #als #lungcancer #merck #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Bayer’s oncology business looks to collect $10B in sales by 2030 — Some experts say FDA made the right call on Lilly's donanemab — Promising IPF treatment results sent Pliant Therapeutics stock soaring -- See more on our front page news http://bit.ly/w28kSd #bayer #oncology #prostatecancer #fda #elililly #donanemab #alzheimers #ipf #pharmanews #pharma #biotech #biotechnology #biopharma #cafepharma